Kura Oncology, Inc. (KURA)
8.55
0.00 (0.00%)
USD |
NASDAQ |
Mar 26, 10:43
Kura Oncology Cash from Investing (Quarterly) : -64.60M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | 4.83M |
| Viemed Healthcare, Inc. | -7.612M |
| Liquidia Corp. | -4.038M |
| Agenus, Inc. | 0.78M |
| Curis, Inc. | 2.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 117.27M |
| Cash from Financing (Quarterly) | 1.135M |
| Free Cash Flow | -70.70M |
| Free Cash Flow Per Share (Quarterly) | 1.306 |
| Free Cash Flow to Equity (Quarterly) | 113.96M |
| Free Cash Flow to Firm (Quarterly) | 115.30M |
| Free Cash Flow Yield | -9.43% |